Contract Research Outsourcing Report 2017 - Rising Late-Stage Services Demand and Budget Restraints Drive Market Growth - Research and Markets

News provided by

May 26, 2017, 13:15 ET

DUBLIN, May 26, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Contract Research Outsourcing - Global Strategic Business Report" report to their offering.

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.

This report analyzes the worldwide markets for Contract Research Outsourcing in US$ Million by the following Service Segments: Drug Discovery, Preclinical Research, and Clinical Research.

The report profiles 115 companies including many key and niche players such as:

Albany Molecular Research, Inc. (USA)
Charles River Laboratories International, Inc. (USA)
Chiltern International Ltd. (UK)
ICON plc (Ireland)
INC Research, LLC (USA)
InVentiv Health, Inc. (USA)
Jubilant Biosys Ltd. (India)
Laboratory Corporation of America® Holdings (USA)
PAREXEL International Corp. (USA)
Pharmaceutical Product Development, LLC. (USA)
Pharmaron (China)
PRA Health Sciences, Inc. (USA)
Quintiles IMS Holdings, Inc. (USA)
Ricerca Biosciences LLC (USA)
Sygnature Discovery Limited (UK)
SynteractHCR (USA)
WuXi AppTec (China)

Key Topics Covered:

1. INDUSTRY OVERVIEW

Outsourcing of R&D Projects to Propel CROs Services Market
Growth Drivers in a Nutshell
Evolving Macro Trends Driving CRO Demand
CROs to Significantly Drive Outsourcing Penetration
Focus on Efficient, Quality Services to Drive Specialty CROs Market
Rise in Investments to Boost Growth
Key Therapeutic Areas of Clinical Trial Research
Pharma and Biotech Companies to Increase Dependence on CROs
Notable Regional Developments
Future Model of CRO

2. COMPETITIVE SCENARIO

A Highly Fragmented Market
Large CROs Seek the Inorganic Growth Route
Global CRO Marketspace
A Review of the M&A Activity in the Recent Years
Select M&A Activity in the Global CRO Market
Noteworthy Contracts of Major CROs
CROs Adept with New Technologies to See More Business in Future
Streamlining Development of Novel Trial Designs
CROs with End-to End Capabilities in Demand
Key Opportunities for CROs
Technological Superiority
A Definite Advantage
Strategies and Tactical Programs for CROs
Survival Strategies in Mature CRO Markets
Exit from the Industry
Expand Scale
Capture Niche Segments
Strategies to Tap Opportunities in Growing Markets
Mobilize Funds
Expand Other Services
Upgrade Technological and Knowledge Base
Form Sub-Contracts or Regional Alliances

3. GROWTH DRIVERS, MARKET TRENDS & ISSUES

Increased Spend on R&D Outsourcing
Enhancing Site Selection and Patient Enrollment
CROs Enter into Alliances to Improve Efficiencies
Adoption of Digital Technologies Gains Pace
Rising Late-Stage Services Demand and Budget Restraints Drive Market Growth
Toxicology Services Gain Notable Attention
Pharma Companies Enter into Licensing Agreements with Biotech Companies for New Drug Discovery
A Mutually Beneficial Strategy
Pharmaceutical & Biopharmaceutical Trends to Support CRO Penetration
Focus on Regulatory Oversight and Enhanced Transparency Bodes Well for CROs
eClinical Solutions Gain Traction
Other Noteworthy Market Trends
CROs Monetize Data
Service Differentiation
A Sustaining Strategy
CROs Tie Up with Diagnostic Companies for Patients
Research Networks Move to Cloud
Application of Mobile Devices to Collect Real Time Data Gains Ground
CROs Provide Exclusive Offers to Lure Big Pharma
Challenges Faced by Contract Research Organizations
On-shore versus Offshore CRO Business
Cutthroat Competition among CROs
Management of Clinical Investigation
Cost Containment
Safety Concerns on Clinical Trials
Pipeline Blocks
Surging Global Population Offers Increased Growth Opportunities

4. CONTRACT RESEARCH OUTSOURCING

Contract Research Organizations (CRO)
Contract Research Outsourcing
Major CRO Services
Ancillary CRO Services
Advantages from CRO
Drug Discovery
Pre-Clinical Studies
Clinical Research
Factors Encouraging CRO Services at Various Phases
Phase I
Phase II
Phase III
Phase IV

5. RECENT INDUSTRY ACTIVITY

WuXi AppTec Takes Over HD Biosciences
Laboratory Corporation of America Holdings to Acquire Pharmaceutical Product Development
PRA Health Sciences and Takeda Pharmaceutical Inks New Partnership
AMRI Enters into Alliance with Bruker Daltonics and HighRes Biosolutions
Pharmaceutical Product Development Establishes Rare Disease and Pediatric Center of Excellence
Pharmaceutical Product Development to Start Clinical Research Unit in Las Vegas
Bracket Acquires CLINapps
PAREXEL International to Acquire ExecuPharm
Cinven to Takeover BioClinica
ICON to Takeover Clinical Research Management
Pharmaceutical Product Development Acquires Evidera
Velocity Fund Partners Acquires Indipharm
Bioclinica Snaps Up Compass Research
Charles River Laboratories International Takes Over Agilux Laboratories
Charles River Laboratories International Snaps Up Blue Stream Laboratories
Charles River Laboratories International Acquires WIL Research
Pharmaron Announces the Acquisition of Quotient Bioresearch
Amulet Capital Partners Acquires SynteractHCR Holdings
IMS Health Merges with Quintiles
Almac Clinical Technologies Enters into Partnership with inVentiv Health
CSSi LifeSciences Unveils Fully Integrated Medical Device CRO
Lovelace Biomedical Commences Operations as Preclinical CRO
PAREXEL International Inks Services Agreement with Pfizer
BioDuro Commences Operations as a Contract Research and Manufacturing Firm
Charles River Laboratories International Forms Partnership with BioMotiv
Laboratory Corporation of America Acquires Covance
Charles River Laboratories International Snaps Up Oncotest
Chiltern Acquires Theorem Clinical Research
Charles River Laboratories International Takes Over Celsis International
Albany Molecular Research Unveils Integrated Drug Discovery Center

6. FOCUS ON SELECT GLOBAL PLAYERS

7. GLOBAL MARKET PERSPECTIVE

Total Companies Profiled: 115 (including Divisions/Subsidiaries 120)

- The United States (47)
- Canada (5)
- Japan (1)
- Europe (27)

- France (2)
- Germany (6)
- The United Kingdom (3)
- Spain (1)
- Rest of Europe (15)

- Asia-Pacific (Excluding Japan) (35)
- Latin America (4)

For more information about this report visit http://www.researchandmarkets.com/research/q6z6wk/contract_research

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets